Histology (melanoma and HER2 negative breast cancer), progressive systemic disease, number of metastases (4–13 vs. 1–3), and occult metastases at time of SRS were found to be predictive of early time to distant CNS failure. The gene discussed is ERBB2; the disease is melanoma.